HDAC-IN-83
HDAC-IN-83 (compound 9D) is an inhibitor of deacetylases (HDACs) (IC50=0.01 μM/0.44 μM HDAC1/HDAC6) with anticancer, antiproliferative and caspase 3/7 activation activities. HDAC-IN-83 inhibits Cal27, HepG2 and MRC-5 with IC50s of 0.693 μM, 0.427 μM and 3.19 μM, respectively[1].
Product Specifications
UNSPSC
12352005
Target
HDAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hdac-in-83.html
Smiles
O=C(C1=CN=C(N2CCC(CN(CC(NC3CCCCC3)=O)C(C4=CC=C(C(C)C)C=C4)=O)CC2)N=C1)NO
Molecular Formula
C29H40N6O4
Molecular Weight
536.67
References & Citations
[1]Stopper D, et al. Multicomponent syntheses enable the discovery of novel quisinostat-derived chemotypes as histone deacetylase inhibitors. Eur J Med Chem. 2025 Jan 5;281:117045.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680999-100 1x 100 µL
Cytokeratin, pan (Cocktail PAN-CK), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
71040 96 Preparations
ITS1-ITS2 Library Preparation Kit for Illumina (Set D)
Sign In for Pricing
View Details 
